| Filed On | Filing |
|---|---|
| 09 Nov 2026 |
8-K: Other Events
Study did not meet primary endpoint of percentage change from baseline in total abscess and inflammatory nodule (AN) count at Week 16 |
| 03 Nov 2026 | EFFECT |
| 27 Oct 2026 | FORM S-3 |
| 27 Oct 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
HENDERSON, Nev.--(BUSINESS WIRE)--October 27, 2026-- Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical‑stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with seriou... |
| 27 Oct 2026 | 10-Q |
| 30 Sep 2026 | FORM S-8 |
| 18 Aug 2026 | 144 |
| 17 Aug 2026 | 144 |
| 17 Aug 2026 |
8-K: Regulation FD Disclosure
2 Forward-Looking Statements Disclaimer This presentation contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate... |
| 14 Aug 2026 | 144 |
| 13 Aug 2026 | 144 |
| 11 Aug 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
HENDERSON, Nev.--(BUSINESS WIRE)--August 11, 2026-- Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical‑stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious... |
| 11 Aug 2026 | 10-Q |
| 01 Jul 2026 |
8-K: Regulation FD Disclosure
©2026 Zura Bio Ltd. 2 Forward-looking statements disclaimer This presentation contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Words such as... |
| 22 Jun 2026 |
Form 3: Mathew Marlyn Teresa, VP, Principal Acctg. Officer
Holds 129,182 shares of Class A Ordinary Shares |
| 22 Jun 2026 |
Form 4: Jarrett Jennifer, Director
Granted 51,000 Share Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Thiara Parvinder, Director
Granted 51,000 Share Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Schoch Steven J, Director
Granted 51,000 Share Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Nirula Ajay, Director
Granted 51,000 Share Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Munshi Amit, Director
Granted 51,000 Share Option (Right to Buy) |
Loading...